|
|
Blood, 15 July 2005, Vol. 106, No. 2, pp. 577-583.
Prepublished online as a Blood First Edition Paper on April 7, 2005; DOI 10.1182/blood-2004-10-4100.
Previous Article | Next Article 
Submitted October 25, 2004
Accepted March 14, 2005
ARF6: A new player in the Fc RIIIA lymphocyte-mediated cytotoxicity
Ricciarda Galandrini*, Federica Micucci, Ilaria Tassi, Maria G Cifone, Benedetta Cinque, Mario Piccoli, Luigi Frati, and Angela Santoni
Department of Experimental Medicine and Pathology, Istituto Pasteur-Fondazione Cenci-Bolognetti, University 'La Sapienza', Rome, Italy
Department of Experimental Medicine, University of L'Aquila, L'Aquila, Italy
Department of Experimental Medicine and Pathology, Istituto Pasteur-Fondazione Cenci-Bolognetti, University 'La Sapienza', Rome, Italy; Istituto Mediterraneo di Neuroscienze 'Neuromed', Pozzilli, Italy
* Corresponding author; email: ricciarda.galandrini{at}uniroma1.it.
The activation of phosphoinositide metabolism represents a critical step in the signaling pathways leading to the activation of cytolytic machinery but its regulation is partially understood. We report here that the stimulation of the low affinity receptor for IgG (FcR IIIA, CD16) on primary human natural killer (NK) cells induces a phosphatidylinositol 3-kinase(PI3K)-dependent activation of the small GTPase Arf6. We firstly demonstrate a functional role for Arf6-dependent signals in the activation of the antibody-dependent cellular cytotoxicity (ADCC) attributable to the control of secretion of lytic granule content. We also show that Arf6 couples CD16 to the lipid modifying enzymes phosphatidylinositol4phosphate 5-kinase type I alpha (PI5KI ) and phospholipase D (PLD) which are involved in the control of granule secretion; Arf6, but not Rho family small G proteins RhoA and Rac1, is required for receptor-induced PI5KI membrane targeting as well as for PI5KI and PLD activation.
Our findings suggest that Arf6 plays a crucial role in the generation of a phosphatidylinositol4,5-bisphosphate (PIP2) plasma membrane pool required for cytolytic granule-mediated target cell killing.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Colonna
Below the NK-cell surface: PIP2.
Blood,
April 15, 2008;
111(8):
3916 - 3916.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Micucci, C. Capuano, E. Marchetti, M. Piccoli, L. Frati, A. Santoni, and R. Galandrini
PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway
Blood,
April 15, 2008;
111(8):
4165 - 4172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Andzelm, X. Chen, K. Krzewski, J. S. Orange, and J. L. Strominger
Myosin IIA is required for cytolytic granule exocytosis in human NK cells
J. Exp. Med.,
October 1, 2007;
204(10):
2285 - 2291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gomez-Cambronero, M. Di Fulvio, and K. Knapek
Understanding phospholipase D (PLD) using leukocytes: PLD involvement in cell adhesion and chemotaxis
J. Leukoc. Biol.,
August 1, 2007;
82(2):
272 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |